JOB SCHEDULER FOR ELECTROMECHANICAL SYSTEM FOR BIOLOGICAL ANALYSES
World Intellectual Property Organization Patent
Stats

Importance

WO Family Size
|
Non-US Coverage
|
Abstract
The present invention relates to a method and system for scheduling a plurality of concurrent job sequences with constraints of precedence and mutual exclusion. In particular the present invention relates to a scheduler for a system performing biological analyses on clinical samples including non-preemptible jobs which must use a set of resources (machines) and having constraints on release times and execution times. Scheduling problem arose in a real industrial system. In principle this problem can be formulated as a case of Real Time Model Checking on a concurrent model such as a Time Petri Net or a Timed Automaton. However, this approach is not viable in the expected runtime embedded platform. The scheduling method according to a preferred embodiment of the present invention exploits on-purpose algorithmic solution that extracts the core of DBM data structures and Floyd-Warshall algorithm from the engine of a full-fledged Model Checking tool and tailors it to the specific requirements of the case. This largely reduces the complexity of search allowing heuristics for sub-optimal solutions and, by mean of incremental algorithmic refinements permits to attain the expected performance requirements.

First Claim
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Country Designations

Patent Owner(s)
Patent Owner | Address |
---|---|
BIOMERIEUX SA | FRFRANCE MAIHEXI - LANTUOA |
International Classification(s)
Inventor(s)
Inventor Name | Address |
---|---|
VICARIO ENRICO | 30030 MARTELLAGO (VE) |
CARIGNANO ANDREA | 51100 PISTOIA |
RIDI LORENZO | 50141 FIRENZE |
TORRINI JACOPO | 50141 FIRENZE |
Cited Art Landscape
- No Cited Art to Display

Full Text

Legal Events

Matter Detail

Renewals Detail

Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:

Add to additional portfolios:

Note
The template below is formatted to ensure compatibility with our system.
Provide tags with | separated like (tags1|tags2).
Maximum length is 128 characters for Customer Application No
Mandatory Fields * - 'MatterType','AppType','Country','Title','SerialNo'.
Acceptable Date Format - 'MM/DD/YYYY'.
Acceptable Filing/App Types -
- Continuation/Divisional
- Original
- Paris Convention
- PCT National
- With Priority
- EP Validation
- Provisional Conversion
- Reissue
- Provisional
- Foreign Extension
Acceptable Status -
- Pending
- Abandoned
- Unfiled
- Expired
- Granted
Acceptable Matter Types -
- Patent
- Utility Model
- Supplemental Protection Certificate
- Design
- Inventor Certificate
- Plant
- Statutory Invention Reg
Advertisement
Advertisement
Advertisement

Recipient Email Address

Recipient Email Address

Comment
Recipient Email Address

Success
E-mail has been sent successfully.
Failure
Some error occured while sending email. Please check e-mail and try again!
Important Notes on Latency of Status data
This Status indicator is an estimation based on the relevant document kind code. As such, it status will only indicate "Published" or "Granted". Expired, lapsed or abandoned statuses are not available in this release. Please refer to the legal status information for more information.
This status should not be taken as legal conclusion. No representations are made as to the accuracy of the status provided. Please consult a legal professional before relying on this status information.
Important Note on Priority Date data
This priority date is an estimated earliest priority date and is purely an estimation. This date should not be taken as legal conclusion. No representations are made as to the accuracy of the date listed. Please consult a legal professional before relying on this date.
Only for Granted EP cases
EP validations represent the countries in which the EP patent may be in force. Data is based on reporting from the various EP contracting states. The reporting consistency can vary across the countries.